Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Ms. Pilar de la Huerta Martinez | CFO & Member of Executive Board | 369k | -- | 1969 |
| Mr. Ludwig M. Lutter | Member of the Executive Board | 435.65k | -- | 1967 |
| Mr. Alexander Richardson | Head of UK Sales Team | -- | -- | -- |
| Dr. Matthias Naumann | Head of Sales & Marketing - Europe | -- | -- | -- |
| Dr. Montserrat Foguet Ph.D. | Managing Director of Biofrontera UK Ltd. | -- | -- | -- |
Biofrontera AG
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 79
Description
Biofrontera AG, a biopharmaceutical company, engages in the research, development, and distribution of dermatological products in Germany, Spain, the United Kingdom, rest of Europe, the United States, and internationally. The company offers Ameluz and BF-RhodoLED lamp for the treatment of mild and moderate actinic keratoses on the face and scalp, field cancerization, and fatal squamous cell carcinoma. It also provides RhodoLED XL lamp for the treatment of multiple interspersed lesions; and Belixos, a cosmetic product for irritated and sensitive skin. The company has a license and supply agreement with Maruho Co., Ltd. Biofrontera AG was founded in 1997 and is headquartered in Leverkusen, Germany.
Corporate Governance
Upcoming Events
November 29, 2024 at 6:30 PM UTC
Biofrontera AG Earnings Date
Recent Events
Recent Events Information Not Available